THBS1, which encodes a matricellular protein and has been proposed as a robust clinical marker of the mesenchymal phenotype and GBM prognosis25,26, was downregulated by 80% in the G⍺12 KD tumors. The gene discussed is THBS1; the disease is glioblastoma.